On November 15, GeLongHui reported that Cinda Real Estate (600657.SH) stated on the interactive platform that its development products mainly focus on residences, with a key emphasis on improving demand and rigid demand, while also moderately developing office buildings and complexes. In the residential sector, the company has formed the Blue Series, Jun Series, and Oriental Series product lines, and in the office sector, it has established the International Series product line, while striving to improve property service levels and commercial operation capabilities. The company's developed projects such as Hangzhou Wen Chao Yi Pin, Hangzhou Cinda Center (Zhen Ao Yuan), Jiaxing Jun Wang Li, and Guangzhou Cinda Jun Yue Lan Ting have won the "Grand Mansion Award." The company has not yet widely applied AI technology, but has used some AI technology in areas such as internet marketing and employee office. The company continues to strengthen its information technology infrastructure, establishing a digital operation system with planning and value as the core, thereby enhancing operational digitization.
- Headlines
- cinda real estate (600657.SH): The company has not yet widely applied AI technology.
信达地产(600657.SH):公司尚未大范围应用AI技术
cinda real estate (600657.SH): The company has not yet widely applied AI technology.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Latest
17:34
The Shanghai Stock Exchange has terminated the IPO review of Zhongchun Gaoke on the Main Board because the sponsor Orient has withdrawn its sponsorship.
Orient+0.10%
17:32
JUNSHI BIO: Triplizumab has received regular approval for second-line and above treatment of melanoma.
JUNSHI BIO+1.81%
17:30
Eurozone January Sentix Investor Confidence Index -17.7, expected -18, previous value -17.5.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.